Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors

被引:25
|
作者
Sakurada, T
Watanabe, C
Okuda, K
Sugiyama, A
Moriyama, T
Sakurada, C
Tan-No, K
Sakurada, S
机构
[1] Daiichi Coll Pharmaceut Sci, Dept Biochem, Minami Ku, Fukuoka 8158511, Japan
[2] Tohoku Pharmaceut Univ, Ctr Lab Anim Sci, Sendai, Miyagi 9818558, Japan
[3] Fukuoka Univ, Dept Internal Med 5, Fukuoka 8140180, Japan
[4] Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9818558, Japan
[5] Tohoku Pharmaceut Univ, Dept Physiol & Antat, Aoba Ku, Sendai, Miyagi 9818558, Japan
来源
MOLECULAR BRAIN RESEARCH | 2002年 / 98卷 / 1-2期
关键词
high-dose morphine; scratching; biting and licking; mouse spinal cord; NMDA receptor; intrathecal injection;
D O I
10.1016/S0169-328X(01)00332-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous research has demonstrated that intrathecal i.t. morphine in a dose of 60.0 nmol into the spinal subarachnoid space of mice can evoke nociceptive behavioral responses consisting of a severe hindlimb scratching directed toward the flank followed by biting/licking of the hindpaw, The present study was undertaken to examine the involvement of spinal N-methyl-D-aspartate (NMDA) and opioid receptors on the behavioral responses evoked by high-dose i.t. morphine. Pretreatment with naloxone, an opioid receptor antagonist (1.0 and 4.0 mg/kg, s.c.), failed to reverse the morphine-evoked behavioral response, suggesting that the morphine effect is not mediated through the opioid receptors in the spinal cord. The morphine-induced behavior was dose-dependently inhibited by i.t. co-administration of the competitive NMDA receptor antagonists, D(-)-2-amino-5-phosphonovaleric acid (D-APV) (6.25-50.0 pmol) and 3-(( +)-2-carboxypiperazin-4-yl)-propyl- I-phosphonic acid (CPP) (3.125-25.0 pmol). The characteristic behavior was also reduced by co-administration of (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5,10-imine maleate (MK-801) (74.1-250 pmol), an NMDA ion-channel blocker. Ifenprodil, a competitive antagonist of the polyamine recognition site of NMDA receptor ion channel complex, produced a dose-related inhibitory effect on the behavioral response to i.t. morphine with less potency than the competitive and non-competitive anatgonists examined. High doses of (+)-HA-966, a glycine/NMDA antagonist, induced a dose-dependent inhibition of morphine-induced response. The effective dose of i.t. 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a non-NMDA receptor antagonist, needed to reduce the morphine-induced response, was approximately 10-fold greater than that Of D-APV. These results suggest that spinal NMDA receptors, but not non-NMDA receptors, may be largely involved in elicitation of the behavioral episode following i.t. injection of morphine in mice. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [1] Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors
    Watanabe, Chizuko
    Orito, Tohru
    Watanabe, Hiroyuki
    Mizoguchi, Hirokazu
    Yonezawa, Akihiko
    Yanai, Kazuhiko
    Mobarakeh, Jalal Izadi
    Onodera, Kenji
    Sakurada, Tsukasa
    Sakurada, Shinobu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 581 (1-2) : 54 - 63
  • [2] Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: Possible involvement of substance P in the mouse spinal cord
    Sakurada, T
    Wako, K
    Sakurada, C
    Manome, Y
    Tanno, K
    Sakurada, S
    Kisara, K
    BRAIN RESEARCH, 1996, 724 (02) : 213 - 221
  • [3] Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors
    Sakurada, S
    Orito, T
    Furuta, S
    Watanabe, H
    Mobarakeh, JI
    Yanai, K
    Watanabe, T
    Sato, T
    Onodera, K
    Sakurada, C
    Sakurada, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 74 (02) : 487 - 493
  • [4] Mechanisms of nociception evoked by intrathecal high-dose morphine
    Sakurada, T
    Komatsu, T
    Sakurada, S
    NEUROTOXICOLOGY, 2005, 26 (05) : 801 - 809
  • [5] INTRATHECAL HIGH-DOSE MORPHINE PRODUCES HYPERALGESIA IN THE RAT
    WOOLF, CJ
    BRAIN RESEARCH, 1981, 209 (02) : 491 - 495
  • [7] HYPERALGESIA AND MYOCLONUS WITH INTRATHECAL INFUSION OF HIGH-DOSE MORPHINE
    DECONNO, F
    CARACENI, A
    MARTINI, C
    SPOLDI, E
    SALVETTI, M
    VENTAFRIDDA, V
    PAIN, 1991, 47 (03) : 337 - 339
  • [8] PHARMACOLOGY OF THE ALLODYNIA IN RATS EVOKED BY HIGH-DOSE INTRATHECAL MORPHINE
    YAKSH, TL
    HARTY, GJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 244 (02): : 501 - 507
  • [9] High-dose intrathecal morphine to control cancer pain - A case report
    Tamakawa, S
    Iwanami, Y
    Ogawa, H
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 15 (01) : 70 - 72
  • [10] TREATMENT OF HIGH-DOSE INTRATHECAL MORPHINE OVERDOSE - CASE-REPORT
    SAUTER, K
    KAUFMAN, HH
    BLOOMFIELD, SM
    CLINE, S
    BANKS, D
    JOURNAL OF NEUROSURGERY, 1994, 81 (01) : 143 - 146